Drugs Approved for Skin Cancer

This page lists cancer drugs approved by the Food and Drug Administration (FDA) for skin cancer, including drugs for basal cell carcinoma, melanoma, and merkel cell carcinoma. The list includes generic names and brand names. The drug names link to NCI's Cancer Drug Information summaries. There may be drugs used in skin cancer that are not listed here.

Drugs Approved for Basal Cell Carcinoma

Aldara (Imiquimod)
Cemiplimab-rwlc
Efudex (Fluorouracil--Topical)
Erivedge (Vismodegib)
5-FU (Fluorouracil--Topical)
Fluorouracil--Topical
Imiquimod
Libtayo (Cemiplimab-rwlc)
Odomzo (Sonidegib)
Sonidegib
Vismodegib

Drugs Approved for Cutaneous Squamous Cell Carcinoma

Cemiplimab-rwlc
Cosibelimab-ipdl
Keytruda (Pembrolizumab)
Libtayo (Cemiplimab-rwlc)
Pembrolizumab
Unloxcyt (Cosibelimab-ipdl)

Drugs Approved for Melanoma

Aldesleukin
Binimetinib
Braftovi (Encorafenib)
Cobimetinib
Cotellic (Cobimetinib)
Dabrafenib
Dacarbazine
DTIC-Dome (Dacarbazine)
Encorafenib
IL-2 (Aldesleukin)
Imlygic (Talimogene Laherparepvec)
Interleukin-2 (Aldesleukin)
Intron A (Recombinant Interferon Alfa-2b)
Ipilimumab
Keytruda (Pembrolizumab)
Kimmtrak (Tebentafusp-tebn)
Lifileucel (Amtagvi)
Mekinist (Trametinib Dimethyl Sulfoxide)
Mektovi (Binimetinib)
Nivolumab
Nivolumab and Relatlimab-rmbw
Opdivo (Nivolumab)
Opdualag (Nivolumab and Relatlimab-rmbw)
Pembrolizumab
Proleukin (Aldesleukin)
Recombinant Interferon Alfa-2b
Tafinlar (Dabrafenib)
Talimogene Laherparepvec
Tebentafusp-tebn
Trametinib Dimethyl Sulfoxide
Tudriqev (Vusolimogene Oderparepvec-wtpg)
Vemurafenib
Vusolimogene Oderparepvec-wtpg
Yervoy (Ipilimumab)
Zelboraf (Vemurafenib)

Drugs Approved for Merkel Cell Carcinoma

Avelumab
Bavencio (Avelumab)
Keytruda (Pembrolizumab)
Pembrolizumab
Retifanlimab-dlwr
Zynyz (Retifanlimab-dlwr )